BridgeMD
New treatment option for Myopia, Progressive
Official title Myopia Control Combined PBM With Myopic Defocus Lens in Children
ClinicalTrials.gov ID: NCT05756959
What this study is testing
- What it's testing
- To study the efficacy of myopi control with two methods: low lever red light and peripheral defocus spectacles with four groups and design with prospective, double-blind, randimized, and with control for 6 month.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 13
You may be able to join if
- Informed consent by the supervision of the children
- 6\~13 years old (including both the 6 and 13)
- SE range: -0.50\~-5.50D
- Astigmatism \<=2.00D
- BCVA \>=0.8
You likely can't join if
- Ocular lesions to effect vision or diseases (such as cataract, glaucoma, marcular pathology, cornea lesions, uveitis, retina detachment, congential...
- Halo, glare, toutic, ADHD, psoriasis
- Systom disease: immune disease, central nerve system, Down syndrome, asthma, severe cardiopulmonary abnormal, severe liver and renal dysfunction.
- Squint, ocular lesion or acute imflammation.
- Other myopia control interventions within recent 3 month such as atropine, device, orthokeratology, multi-focus soft lens, multi-function spectacles.
See the full eligibility criteria
- Informed consent by the supervision of the children
- 6\~13 years old (including both the 6 and 13)
- SE range: -0.50\~-5.50D
- Astigmatism \<=2.00D
- BCVA \>=0.8
- Anisometropia \<=1.50D
- Confirmed to no use of other myopia control intervention
- Ocular lesions to effect vision or diseases (such as cataract, glaucoma, marcular pathology, cornea lesions, uveitis, retina detachment, congential opitc abnormal and etc.)
- Halo, glare, toutic, ADHD, psoriasis
- Systom disease: immune disease, central nerve system, Down syndrome, asthma, severe cardiopulmonary abnormal, severe liver and renal dysfunction.
- Squint, ocular lesion or acute imflammation.
- Other myopia control interventions within recent 3 month such as atropine, device, orthokeratology, multi-focus soft lens, multi-function spectacles.
The study team makes the final eligibility decision.
Where it's taking place
- Xuzhou, Jiangsu, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 13 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Xuzhou, Jiangsu, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.